These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17196900)

  • 1. Failure of pain control using transdermal fentanyl during rifampicin treatment.
    Morii H; Chiba M; Konishi H; Endo Y; Yamaji A
    J Pain Symptom Manage; 2007 Jan; 33(1):5-6. PubMed ID: 17196900
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampin reduces the analgesic effect of transdermal fentanyl.
    Takane H; Nosaka A; Wakushima H; Hosokawa K; Ieiri I
    Ann Pharmacother; 2005 Dec; 39(12):2139-40. PubMed ID: 16288064
    [No Abstract]   [Full Text] [Related]  

  • 3. A pitfall to avoid when starting a patient on transdermal fentanyl.
    Low JA; Chye R
    Aust Fam Physician; 2000 Dec; 29(12):1173-5. PubMed ID: 11140227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe withdrawal from short-term transdermal fentanyl after naloxone for uremic pruritus.
    Finsterer J; Keller H; Arias I; Zuntner G
    J Pain Symptom Manage; 2004 May; 27(5):387-8. PubMed ID: 15120761
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
    Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
    Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain.
    Kress HG; Von der Laage D; Hoerauf KH; Nolte T; Heiskanen T; Petersen R; Lundorff L; Sabatowski R; Krenn H; Rosland JH; Saedder EA; Jensen NH
    J Pain Symptom Manage; 2008 Sep; 36(3):268-79. PubMed ID: 18538974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of transdermal fentanyl in chronic non-malignant pain].
    Akkaya T; Sayin M; Gümüş H
    Agri; 2005 Jan; 17(1):39-44. PubMed ID: 15791499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
    Worrich S; Schuler G; Janicki PK
    Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.
    Berliner MN; Giesecke T; Bornhövd KD
    Clin J Pain; 2007; 23(6):530-4. PubMed ID: 17575494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the clinical trial of transdermal therapeutic system-fentanyl in strong opioid pre-treated adult patients with cancer-related pain.
    Besova N; Gorbounova V; Saltanov A; Zarouk V
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():378-84. PubMed ID: 10895182
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effective pain therapy with good tolerability. New opioid administration form by transdermal patch].
    MMW Fortschr Med; 2005 Nov; 147(46):66-7. PubMed ID: 16358643
    [No Abstract]   [Full Text] [Related]  

  • 12. [Perioperative management of patients with cancer-pain receiving fentanyl patch].
    Takahashi R; Waseda Y; Nitta S
    Masui; 2008 Jul; 57(7):886-8. PubMed ID: 18649645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-cycle fentanyl patch system significantly improves pain control in gynecologic cancer.
    Kanamori C; Kanamori T; Hayashi M; Yorioka H; Kanzaki H
    J Obstet Gynaecol Res; 2006 Dec; 32(6):605-9. PubMed ID: 17100824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transdermal fentanyl dependency in the treatment of chronic pain in the elderly: presentation of a case].
    Calle Egusquiza A; Planas Domingo J; Farriols Danés C
    Rev Esp Geriatr Gerontol; 2011; 46(3):179. PubMed ID: 21477893
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of pain with opioid analgesics and the role of TTS-fentanyl (Durogesic)].
    Persoli-Gudelj M
    Reumatizam; 2001; 48(2):29-33, 36-7. PubMed ID: 12476746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' knowledge of transdermal fentanyl.
    Lidstone V; Owen R
    Palliat Med; 2005 Oct; 19(7):566-7; author reply 567-8. PubMed ID: 16295292
    [No Abstract]   [Full Text] [Related]  

  • 17. Transdermal fentanyl in cachectic cancer patients.
    Heiskanen T; Mätzke S; Haakana S; Gergov M; Vuori E; Kalso E
    Pain; 2009 Jul; 144(1-2):218-22. PubMed ID: 19442446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absence of 'cross-tolerance' when switching from oral morphine to transdermal fentanyl.
    Johnson S; Faull C
    Palliat Med; 1997 Nov; 11(6):494-5. PubMed ID: 9519176
    [No Abstract]   [Full Text] [Related]  

  • 20. Using high-dose fentanyl patches.
    Lilley LL; Guanci R
    Am J Nurs; 1996 Jul; 96(7):18-20, 22. PubMed ID: 8659562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.